维业股份(300621) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥633,611,080.46, a decrease of 0.70% compared to the same period last year[7]. - Net profit attributable to shareholders of the listed company was ¥16,955,342.70, down 5.65% year-on-year[7]. - Basic earnings per share for the reporting period was ¥0.08, a decrease of 11.11% compared to the same period last year[7]. - The weighted average return on net assets was 1.88%, a decrease of 0.15% year-on-year[7]. - The company's operating revenue for Q3 2019 was CNY 507.27 million, a decrease of 17.3% compared to CNY 613.81 million in the same period last year[38]. - The net profit for Q3 2019 was CNY 17.41 million, representing a 2.5% increase from CNY 16.98 million in Q3 2018[36]. - The total profit for Q3 2019 was CNY 19.97 million, up from CNY 18.31 million in the previous year, marking an increase of 9.1%[36]. - The company's total revenue for the year-to-date period reached CNY 1.85 billion, an increase of 6.8% from CNY 1.74 billion in the previous year[41]. - The total operating costs for the year-to-date period were CNY 1.75 billion, up from CNY 1.63 billion, indicating a rise in operational expenses[41]. - The company's operating revenue for the current period is CNY 1,588,209,278.72, a decrease of 6.1% compared to CNY 1,691,775,243.82 in the previous period[46]. - The net profit for the current period is CNY 76,732,773.26, representing an increase of 4.3% from CNY 73,624,059.39 in the previous period[44]. - The total profit for the current period is CNY 89,807,119.68, down from CNY 96,390,871.62 in the previous period, reflecting a decrease of 6.0%[46]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,618,548,575.64, an increase of 7.30% compared to the previous year[7]. - Net assets attributable to shareholders of the listed company were ¥936,785,913.92, up 8.72% year-on-year[7]. - The company's total assets as of September 30, 2019, amounted to CNY 2,372,763,531.91, an increase from CNY 2,286,782,726.06 at the end of 2018[32]. - The total liabilities increased to CNY 1,645,465,718.31 from CNY 1,546,165,551.91 year-over-year[27]. - The total current liabilities amounted to CNY 1,639,656,468.35, compared to CNY 1,538,626,989.42 in the previous year, reflecting an increase of 6.6%[27]. - Total liabilities reached CNY 1,546,165,551.91, with current liabilities at CNY 1,538,626,989.42 and non-current liabilities at CNY 7,538,562.49[61]. - The total liabilities to equity ratio stands at approximately 1.73, indicating a leveraged position[61]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥32,714,744.90, an increase of 8.45%[7]. - The net cash flow from operating activities for Q3 2019 was CNY 32,714,744.90, an increase from CNY 30,165,524.35 in Q3 2018, reflecting a growth of approximately 8.5%[51]. - Total cash inflow from operating activities was CNY 1,869,669,319.85, while cash outflow was CNY 1,836,954,574.95, resulting in a net cash inflow of CNY 32,714,744.90[51]. - The net cash flow from investing activities was CNY 141,882,753.38, a significant improvement compared to a net outflow of CNY 86,781,679.21 in the previous year[52]. - Cash inflow from financing activities totaled CNY 534,196,846.77, while cash outflow was CNY 632,978,188.93, leading to a net cash outflow of CNY 98,781,342.16[52]. - The ending balance of cash and cash equivalents was CNY 482,213,543.50, up from CNY 400,449,518.62 at the end of Q3 2018, indicating a year-over-year increase of approximately 20.4%[52]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,429[11]. - The top shareholder, Shenzhen Weiye Holdings Co., Ltd., held 38.30% of the shares, amounting to 79,749,000 shares[11]. Research and Development - Research and development expenses increased significantly to CNY 17,635,789.53, compared to CNY 3,038,308.79 in the previous year, reflecting a growth of 480.5%[34]. - The company incurred research and development expenses of CNY 50,685,112.29, significantly higher than CNY 8,171,751.55 in the previous period, indicating a focus on innovation[46]. - The company's R&D expenses in Q3 2019 were CNY 17.64 million, significantly higher than CNY 3.04 million in Q3 2018, indicating a focus on innovation[38]. Other Financial Metrics - Non-recurring gains and losses included government subsidies of ¥2,355,985.79[8]. - The company's cash and cash equivalents decreased to CNY 463,295,440.05 from CNY 475,388,282.94 at the end of 2018, reflecting a decline of approximately 2.3%[24]. - Accounts receivable increased significantly to CNY 1,627,299,548.93, up from CNY 1,365,314,143.67, representing a growth of about 19.2%[24]. - The company's inventory decreased to CNY 95,654,777.35 from CNY 104,817,644.61, a decline of 8.8%[30]. - The company reported a credit impairment loss of CNY -16,737,098.58 for the current period[43]. - The company has seen a decrease in sales costs, which are CNY 1,334,180,791.27 for the current period, down from CNY 1,471,062,480.59 in the previous period[46]. Legal and Compliance - The company is involved in ongoing litigation related to contract disputes, with claims amounting to CNY 953,570.72 plus interest[19]. - There were no violations regarding external guarantees or non-operating fund occupation by major shareholders during the reporting period[20].